medicare coverage for semaglutide 💉 is making popular weight-loss medications more affordable some patients. Starting July 1, 2026, eligible Medicare beneficiaries may be able to access certain GLP-1 weight-loss drugs for just $50 per Medicare should wait on approving

Medication adjustments may be needed

She explains that flexible tapering strategies are key to successful antidepressant discontinuation in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care Dietitian Sarah MacAvoy explains that while new weight-loss medications show exciting potential, they also put patients at risk of nutritional deficiencies, and dietitian support is essential Kia ora and welcome to Pharmacy Today Kaitiaki Rongo O Te W Not a subscriber

Thats pure, Krause said, pointing to the spike

injected GLP-1 analog, liraglutide (LIR), into mice

After 40, the limiting factor is almost never effort

But this program operates outside of the Part D benefit, and that $50 does not count towards the patients Part D deductible or out-of-pocket max